Summary
A federal vaccine advisory committee has delayed its decision on whether newborns should receive the hepatitis B vaccine on the day they are born. The meeting will continue on Friday, December 5, when the committee will revisit the decision.
Key Facts
- A federal vaccine advisory committee met to discuss hepatitis B vaccinations for newborns.
- The committee decided to delay the vote until Friday.
- There was confusion among committee members about the voting process.
- The committee is the Advisory Committee on Immunization Practices.
- Hepatitis B vaccines for newborns have been recommended by the government for decades.
- The vaccine is credited with preventing thousands of liver infections.
- The meeting takes place in Atlanta.
